The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4
The efficacy of the novel fluoroquinolone Console Overlay finafloxacin was evaluated as a potential therapeutic in vitro and in vivo, following an intranasal infection of Francisella tularensis strain SchuS4 in BALB/c mice.We demonstrated that short treatment courses of finafloxacin provide high levels of protection, with a single dose resulting in